🏥MS. XINLI SHI: ACADEMIC AND PROFESSIONAL PROFILE
🎓EARLY ACADEMIC PURSUITS
Ms. Xinli Shi, a Chinese national, began her academic journey with a B.Sc. in Biochemistry from the Department of Bioengineering at Hebei University of Science and Technology (1996–2001). She deepened her expertise in immunological mechanisms with an M.Sc. in Medical Immunology (2003–2007) from Hebei Medical University, followed by a Ph.D. in Immunology (2011–2014) from the West China College of Basic Medicine and Forensic Medicine, Sichuan University—one of China’s top-tier medical schools.
🩺PROFESSIONAL ENDEAVORS
Prof. Shi’s academic career spans over two decades, reflecting progressive growth:
-
2001–2013: She served at Hebei Medical University as a Teaching Assistant and then Lecturer, establishing foundational teaching experience.
-
2013–2018: Appointed Associate Professor and Master’s Supervisor at the School of Basic Medicine, Hebei University of Chinese Medicine.
-
2015–2017: Completed a Postdoctoral Fellowship at the Bethune International Peace Hospital, affiliated with the Third Military Medical University, focusing on advanced clinical research.
-
2018–2023: Promoted to Professor and Doctoral Supervisor at Hebei University of Chinese Medicine.
-
2023–Present: Serving as Professor and Doctoral/Master Supervisor at the Experimental Management Center, Shanxi University of Chinese Medicine.
🔬CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR
Prof. Shi has made notable contributions in the field of tumor immunology, particularly within the tumor microenvironment, focusing on:
Her research explores how immune signaling and cellular stress responses shape tumor progression and therapeutic resistance, offering novel targets for immunomodulatory and chemotherapeutic interventions.
She has guided:
🌍IMPACT AND INFLUENCE
Prof. Shi’s work is highly regarded in both Western medicine and Traditional Chinese Medicine (TCM) circles. Her interdisciplinary approach integrates modern immunology with TCM principles, enabling translational applications in cancer and chronic disease therapy. She has been part of numerous provincial and national talent programs, contributing to science policy and medical education reform.
🏆RESEARCH GRANTS AND FUNDING
Prof. Shi has led 14 research projects, funded by prestigious national and provincial bodies. These include:
-
2 National Natural Science Foundation of China (NSFC) grants (No. 81873112 & 82274315)
-
China Postdoctoral Science Foundation
-
Hebei Natural Science Foundation (multiple years)
-
Shanxi Science and Technology Department
-
Shanxi Provincial Administration of Traditional Chinese Medicine Innovation Team
🔹 Total grant portfolio spans over a decade, supporting basic, translational, and clinical research initiatives.
🏆LEGACY AND FUTURE CONTRIBUTIONS
Prof. Shi’s career exemplifies academic excellence, clinical relevance, and mentorship. With growing involvement in Shanxi’s TCM innovation programs, she is positioned to pioneer integrative oncology in China—blending evidence-based traditional practices with cutting-edge immunotherapy research. Her future directions include:
-
Building innovation teams
-
Leading multi-center translational studies
-
Expanding doctoral and postdoctoral programs
-
Enhancing international collaborations in cancer research
🧬CONCLUSION
Prof. Xinli Shi stands at the confluence of biochemistry, medical immunology, and TCM oncology, with over 20 years of academic and clinical experience. Her dedication to tumor biology, immune modulation, and interdisciplinary research continues to shape the landscape of cancer therapeutics in China. As a mentor, scholar, and innovator, she contributes profoundly to the development of next-generation scientists and the advancement of personalized medicine.